Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Theralase® Technologies Inc.

Clinical trials sponsored by Theralase® Technologies Inc., explained in plain language.

Theralase Technologies Inc. TLT TSX VENTURE

Medical device and biotech company focused on photodynamic therapy for cancer and pain.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1

New hope for bladder cancer patients who failed standard treatment

Disease control Recruiting now

This study tests a new drug called Ruvidar, given directly into the bladder, for people with a type of bladder cancer that did not respond to or could not tolerate standard BCG therapy. About 90 adults will receive up to three treatment sessions. The main goal is to see if the dr…

Phase: PHASE2 • Sponsor: Theralase® Technologies Inc. • Aim: Disease control

Last updated Jun 27, 2026 07:59 UTC